Escherichia coli O157: H7 (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Escherichia coli O157: H7" in Italian language version.

refsWebsite

Global rank Italian rank

6nih.gov

4^th place

9^th place

5doi.org

2^nd place

7^th place

3oadoi.org

799^th place

22^nd place

2archive.org

6^th place

8^th place

1books.google.com

3^rd place

14^th place

1jrank.org

6,917^th place

5,269^th place

archive.org

MJ. Medellin-Peña, H. Wang; R. Johnson; S. Anand; MW. Griffiths, Probiotics affect virulence-related gene expression in Escherichia coli O157:H7., in Appl Environ Microbiol, vol. 73, n. 13, luglio 2007, pp. 4259-67, DOI:10.1128/AEM.00159-07, PMID 17496132.
H. Eutamene, L. Bueno, Role of probiotics in correcting abnormalities of colonic flora induced by stress., in Gut, vol. 56, n. 11, novembre 2007, pp. 1495-7, DOI:10.1136/gut.2007.124040, PMID 17938427.

books.google.com

Mauro Moroni, Roberto Esposito e Fausto De Lalla, Malattie infettive, Elsevier srl, 2008, pp. 494–, ISBN 978-88-214-2980-4.

doi.org

dx.doi.org

Karch H, Tarr P, Bielaszewska M, Enterohaemorrhagic Escherichia coli in human medicine., in Int J Med Microbiol, vol. 295, n. 6-7, 2005, pp. 405–18, DOI:10.1016/j.ijmm.2005.06.009, PMID 16238016.
S. Fukuda, H. Toh; K. Hase; K. Oshima; Y. Nakanishi; K. Yoshimura; T. Tobe; JM. Clarke; DL. Topping; T. Suzuki; TD. Taylor, Bifidobacteria can protect from enteropathogenic infection through production of acetate., in Nature, vol. 469, n. 7331, gennaio 2011, pp. 543-7, DOI:10.1038/nature09646, PMID 21270894.
MJ. Medellin-Peña, H. Wang; R. Johnson; S. Anand; MW. Griffiths, Probiotics affect virulence-related gene expression in Escherichia coli O157:H7., in Appl Environ Microbiol, vol. 73, n. 13, luglio 2007, pp. 4259-67, DOI:10.1128/AEM.00159-07, PMID 17496132.
N. Jandu, ZJ. Zeng; KC. Johnson-Henry; PM. Sherman, Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1., in Microbiology, vol. 155, Pt 2, febbraio 2009, pp. 531-40, DOI:10.1099/mic.0.021931-0, PMID 19202101.
H. Eutamene, L. Bueno, Role of probiotics in correcting abnormalities of colonic flora induced by stress., in Gut, vol. 56, n. 11, novembre 2007, pp. 1495-7, DOI:10.1136/gut.2007.124040, PMID 17938427.

jrank.org

science.jrank.org

Escherichia coli - Intestinal, Bacterium, Tract, Strain, Water, and Disease, su science.jrank.org. URL consultato il 28 maggio 2011.

nih.gov

ncbi.nlm.nih.gov

Karch H, Tarr P, Bielaszewska M, Enterohaemorrhagic Escherichia coli in human medicine., in Int J Med Microbiol, vol. 295, n. 6-7, 2005, pp. 405–18, DOI:10.1016/j.ijmm.2005.06.009, PMID 16238016.
S. Fukuda, H. Toh; K. Hase; K. Oshima; Y. Nakanishi; K. Yoshimura; T. Tobe; JM. Clarke; DL. Topping; T. Suzuki; TD. Taylor, Bifidobacteria can protect from enteropathogenic infection through production of acetate., in Nature, vol. 469, n. 7331, gennaio 2011, pp. 543-7, DOI:10.1038/nature09646, PMID 21270894.
MJ. Medellin-Peña, H. Wang; R. Johnson; S. Anand; MW. Griffiths, Probiotics affect virulence-related gene expression in Escherichia coli O157:H7., in Appl Environ Microbiol, vol. 73, n. 13, luglio 2007, pp. 4259-67, DOI:10.1128/AEM.00159-07, PMID 17496132.
N. Jandu, ZJ. Zeng; KC. Johnson-Henry; PM. Sherman, Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1., in Microbiology, vol. 155, Pt 2, febbraio 2009, pp. 531-40, DOI:10.1099/mic.0.021931-0, PMID 19202101.
H. Eutamene, L. Bueno, Role of probiotics in correcting abnormalities of colonic flora induced by stress., in Gut, vol. 56, n. 11, novembre 2007, pp. 1495-7, DOI:10.1136/gut.2007.124040, PMID 17938427.
Y. Kim, SH. Kim; KY. Whang; YJ. Kim; S. Oh, Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells., in J Microbiol Biotechnol, vol. 18, n. 7, luglio 2008, pp. 1278-85, PMID 18667857.

oadoi.org

Karch H, Tarr P, Bielaszewska M, Enterohaemorrhagic Escherichia coli in human medicine., in Int J Med Microbiol, vol. 295, n. 6-7, 2005, pp. 405–18, DOI:10.1016/j.ijmm.2005.06.009, PMID 16238016.
S. Fukuda, H. Toh; K. Hase; K. Oshima; Y. Nakanishi; K. Yoshimura; T. Tobe; JM. Clarke; DL. Topping; T. Suzuki; TD. Taylor, Bifidobacteria can protect from enteropathogenic infection through production of acetate., in Nature, vol. 469, n. 7331, gennaio 2011, pp. 543-7, DOI:10.1038/nature09646, PMID 21270894.
N. Jandu, ZJ. Zeng; KC. Johnson-Henry; PM. Sherman, Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1., in Microbiology, vol. 155, Pt 2, febbraio 2009, pp. 531-40, DOI:10.1099/mic.0.021931-0, PMID 19202101.